Results 31 to 40 of about 161,533 (212)

The Treatment of IgA Nephropathy [PDF]

open access: yesKidney Diseases, 2015
<b><i>Background:</i></b> IgA nephropathy (IgAN) is a very common glomerulonephritis worldwide. Nevertheless, treatment options for primary IgAN are still largely based on opinion or weak evidence. There is a lack of large randomized controlled trials (RCT) that provide a definitive immunosuppressive protocol for IgAN.
Leung, JCK, Lai, KN, Tang, SCW
openaire   +4 more sources

The Role of IgA in the Pathogenesis of IgA Nephropathy [PDF]

open access: yesInternational Journal of Molecular Sciences, 2019
Immunoglobulin A (IgA) is the most abundant antibody isotype produced in humans, predominantly present in the mucosal areas where its main functions are the neutralization of toxins, prevention of microbial invasion across the mucosal epithelial barrier, and simultaneous maintenance of a physiologically indispensable symbiotic relationship with ...
Martina Perše, Željka Večerić-Haler
openaire   +3 more sources

Integration of three machine learning algorithms identifies characteristic RNA binding proteins linked with diagnosis, immunity and pyroptosis of IgA nephropathy

open access: yesFrontiers in Genetics, 2022
Objective: RNA-binding proteins (RBPs) are essential for most post-transcriptional regulatory events, which exert critical roles in nearly all aspects of cell biology.
Xueqin Zhang   +7 more
doaj   +1 more source

IgA nephropathy in a patient with ankylosing spondylitis well controlled with etanercept [PDF]

open access: yesKosin Medical Journal, 2018
Ankylosing spondylitis (AS) can involve the eye, gastrointestinal system, cardiopulmonary system, skin, kidneys, and spinal and peripheral joints. It is rarely accompanied by immunoglobulin A (IgA) nephropathy. Although IgA is involved in both AS and IgA
Do-Hyeong Lee   +3 more
doaj   +1 more source

Aspirin alleviates the symptoms of immunoglobulin A nephropathy via suppressing platelets-mediated non-canonical NF-κB activation in B cells

open access: yesSTEMedicine, 2023
Purpose: Antiplatelet aggregation drugs, such as aspirin, can alleviate pathological renal damage in immunoglobulin A (IgA) nephropathy, although the precise mechanism is unclear.
Nomvula Johannes, Priyanka Maunga
doaj   +1 more source

IgA Glycosylation in IgA Nephropathy [PDF]

open access: yes, 1998
IgA nephropathy (IgAN) is the commonest form of glomerulonephritis in developed countries where renal biopsy is widely practiced1. IgAN is defined by the deposition of IgA in the glomerular mesangium. Most typically, patients present with episodes of visible haematuria, which often concide with respiratory or gastrointestinal infection.
A, Allen, J, Feehally
openaire   +2 more sources

Use of gas chromatography mass spectrometry to elucidate metabolites predicting the phenotypes of IgA nephropathy in hyper IgA mice.

open access: yesPLoS ONE, 2019
IgA nephropathy, a common chronic kidney disease, has various possible outcomes. Therefore, the identification of novel prognostic biomarkers is needed.
Makoto Kurano, Yutaka Yatomi
doaj   +1 more source

IgA nephropathy enigma [PDF]

open access: yesClinical Immunology, 2016
IgA nephropathy (IgAN) is the leading cause of primary glomerulonephritis in the world. The disease is characterized by the presence of IgA-containing immune complexes in the circulation and in mesangial deposits with ensuing glomerular injury. Although in humans there are two IgA subclasses, only IgA1 molecules are involved.
Jiri, Mestecky   +3 more
openaire   +2 more sources

Advances in genetics of Immunoglobulin A Nephropathy.

open access: yes, 2016
In the chapter genetic characteristics of IgA Nephropathy are ...
Ali Gharavi   +5 more
core   +1 more source

Novel Treatment Paradigms: Primary IgA Nephropathy

open access: yesKidney International Reports
IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Approximately 30% to 45% of patients progress to kidney failure (KF) within 20 to 25 years of diagnosis, and there has long been a lack of effective treatments.
Haresh Selvaskandan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy